Chengdu Brilliant Pharmaceutical Co., Ltd.
3 clinical trials · Sponsor
◉ Watch Chengdu Brilliant Pharmaceutical Co., Ltd.
| Record | Firm | Date |
|---|---|---|
| A Safety and Tolerability Study of BPR-30221616 Injection in Healthy Subjects (NCT06760455) | Chengdu Brilliant Pharmaceutical Co., Ltd. | 2025-01-10 |
| Efficacy and Safety of Semaglutide Injection in Subjects With Type 2 Diabetes (NCT06339086) | Chengdu Brilliant Pharmaceutical Co., Ltd. | 2024-04-01 |
| The Efficacy and Safety of Esketamine in Elective Laparoscopic Surgery (NCT06092684) | Chengdu Brilliant Pharmaceutical Co., Ltd. | 2023-09-20 |
Track Chengdu Brilliant Pharmaceutical Co., Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.